APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brucella Abortus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Brucella Abortus Vaccine Market Analysis and Forecast 2026-2032

21 December 2025217 pages

Choose your research edition.

Industry ResearchBrucella Abortus Vaccine Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Brucella Abortus Vaccine Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Brucella Abortus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brucella Abortus Vaccine Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Brucella Abortus Vaccine Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Brucella Abortus Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Brucella Abortus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Brucella Abortus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Brucella Abortus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Brucella Abortus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Brucella Abortus Vaccine include Zoetis, Qilu Animal Health, Merck Animal Health, Vetal, VECOL, Tecnovax, SYVA Laboratorios, Onderstepoort Biological Products and Merial, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Brucella Abortus Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Brucella Abortus Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Brucella Abortus Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Brucella Abortus Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Brucella Abortus Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Brucella Abortus Vaccine sales, projected growth trends, production technology, application and end-user industry.

Brucella Abortus Vaccine Segment by Company

Zoetis

Qilu Animal Health

Merck Animal Health

Vetal

VECOL

Tecnovax

SYVA Laboratorios

Onderstepoort Biological Products

Merial

JOVAC

Instituto Rosenbusch

Institute of Animal Health and Veterinary Biologicals

Indian Immunologicals

Hester Biosciences

Dollvet

CZ Veterinaria

Colorado Serum Company

CEVA

Centro Diagnostico Veterinario

CAVAC

Biovet

Biogenesis Bago

Brucella Abortus Vaccine Segment by Type

Vector Vaccines

Subunit Vaccines

DNA Vaccines

B. Abortus Recombinant Mutants

Others

Brucella Abortus Vaccine Segment by Application

Pigs

Sheep

Cattles

Others

Brucella Abortus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucella Abortus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brucella Abortus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucella Abortus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Brucella Abortus Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Brucella Abortus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Brucella Abortus Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Brucella Abortus Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Vector Vaccines Major Manufacturers Table 3. Subunit Vaccines Major Manufacturers Table 4. DNA Vaccines Major Manufacturers Table 5. B. Abortus Recombinant Mutants Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Brucella Abortus Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Pigs Major Manufacturers Table 9. Sheep Major Manufacturers Table 10. Cattles Major Manufacturers Table 11. Others Major Manufacturers Table 12. Brucella Abortus Vaccine Industry Trends Table 13. Brucella Abortus Vaccine Industry Drivers Table 14. Brucella Abortus Vaccine Industry Opportunities and Challenges Table 15. Brucella Abortus Vaccine Industry Restraints Table 16. Global Brucella Abortus Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Brucella Abortus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Brucella Abortus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Brucella Abortus Vaccine Revenue Market Share by Region (2021-2026) Table 20. Global Brucella Abortus Vaccine Revenue Market Share by Region (2027-2032) Table 21. Global Brucella Abortus Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Brucella Abortus Vaccine Sales by Region (2021-2026) & (k units) Table 23. Global Brucella Abortus Vaccine Sales by Region (2027-2032) & (k units) Table 24. Global Brucella Abortus Vaccine Sales Market Share by Region (2021-2026) Table 25. Global Brucella Abortus Vaccine Sales Market Share by Region (2027-2032) Table 26. Global Brucella Abortus Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Brucella Abortus Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Brucella Abortus Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Brucella Abortus Vaccine Sales Market Share by Manufacturers (2021-2026) Table 30. Global Brucella Abortus Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global Brucella Abortus Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Brucella Abortus Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Brucella Abortus Vaccine Manufacturers, Product Type & Application Table 34. Global Brucella Abortus Vaccine Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Brucella Abortus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Brucella Abortus Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Brucella Abortus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Brucella Abortus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Brucella Abortus Vaccine Revenue Market Share by Type (2021-2026) Table 41. Global Brucella Abortus Vaccine Revenue Market Share by Type (2027-2032) Table 42. Global Brucella Abortus Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 44. Global Brucella Abortus Vaccine Sales by Type (2027-2032) & (k units) Table 45. Global Brucella Abortus Vaccine Sales Market Share by Type (2021-2026) Table 46. Global Brucella Abortus Vaccine Sales Market Share by Type (2027-2032) Table 47. Global Brucella Abortus Vaccine Price by Type (2021-2026) & (US$/unit) Table 48. Global Brucella Abortus Vaccine Price by Type (2027-2032) & (US$/unit) Table 49. Global Brucella Abortus Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Brucella Abortus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Brucella Abortus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Brucella Abortus Vaccine Revenue Market Share by Application (2021-2026) Table 53. Global Brucella Abortus Vaccine Revenue Market Share by Application (2027-2032) Table 54. Global Brucella Abortus Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 56. Global Brucella Abortus Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Brucella Abortus Vaccine Sales Market Share by Application (2021-2026) Table 58. Global Brucella Abortus Vaccine Sales Market Share by Application (2027-2032) Table 59. Global Brucella Abortus Vaccine Price by Application (2021-2026) & (US$/unit) Table 60. Global Brucella Abortus Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. Zoetis Company Information Table 62. Zoetis Business Overview Table 63. Zoetis Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Zoetis Brucella Abortus Vaccine Product Portfolio Table 65. Zoetis Recent Development Table 66. Qilu Animal Health Company Information Table 67. Qilu Animal Health Business Overview Table 68. Qilu Animal Health Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Qilu Animal Health Brucella Abortus Vaccine Product Portfolio Table 70. Qilu Animal Health Recent Development Table 71. Merck Animal Health Company Information Table 72. Merck Animal Health Business Overview Table 73. Merck Animal Health Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Merck Animal Health Brucella Abortus Vaccine Product Portfolio Table 75. Merck Animal Health Recent Development Table 76. Vetal Company Information Table 77. Vetal Business Overview Table 78. Vetal Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Vetal Brucella Abortus Vaccine Product Portfolio Table 80. Vetal Recent Development Table 81. VECOL Company Information Table 82. VECOL Business Overview Table 83. VECOL Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. VECOL Brucella Abortus Vaccine Product Portfolio Table 85. VECOL Recent Development Table 86. Tecnovax Company Information Table 87. Tecnovax Business Overview Table 88. Tecnovax Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Tecnovax Brucella Abortus Vaccine Product Portfolio Table 90. Tecnovax Recent Development Table 91. SYVA Laboratorios Company Information Table 92. SYVA Laboratorios Business Overview Table 93. SYVA Laboratorios Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. SYVA Laboratorios Brucella Abortus Vaccine Product Portfolio Table 95. SYVA Laboratorios Recent Development Table 96. Onderstepoort Biological Products Company Information Table 97. Onderstepoort Biological Products Business Overview Table 98. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Onderstepoort Biological Products Brucella Abortus Vaccine Product Portfolio Table 100. Onderstepoort Biological Products Recent Development Table 101. Merial Company Information Table 102. Merial Business Overview Table 103. Merial Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Merial Brucella Abortus Vaccine Product Portfolio Table 105. Merial Recent Development Table 106. JOVAC Company Information Table 107. JOVAC Business Overview Table 108. JOVAC Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. JOVAC Brucella Abortus Vaccine Product Portfolio Table 110. JOVAC Recent Development Table 111. Instituto Rosenbusch Company Information Table 112. Instituto Rosenbusch Business Overview Table 113. Instituto Rosenbusch Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Instituto Rosenbusch Brucella Abortus Vaccine Product Portfolio Table 115. Instituto Rosenbusch Recent Development Table 116. Institute of Animal Health and Veterinary Biologicals Company Information Table 117. Institute of Animal Health and Veterinary Biologicals Business Overview Table 118. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Portfolio Table 120. Institute of Animal Health and Veterinary Biologicals Recent Development Table 121. Indian Immunologicals Company Information Table 122. Indian Immunologicals Business Overview Table 123. Indian Immunologicals Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Indian Immunologicals Brucella Abortus Vaccine Product Portfolio Table 125. Indian Immunologicals Recent Development Table 126. Hester Biosciences Company Information Table 127. Hester Biosciences Business Overview Table 128. Hester Biosciences Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Hester Biosciences Brucella Abortus Vaccine Product Portfolio Table 130. Hester Biosciences Recent Development Table 131. Dollvet Company Information Table 132. Dollvet Business Overview Table 133. Dollvet Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Dollvet Brucella Abortus Vaccine Product Portfolio Table 135. Dollvet Recent Development Table 136. CZ Veterinaria Company Information Table 137. CZ Veterinaria Business Overview Table 138. CZ Veterinaria Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. CZ Veterinaria Brucella Abortus Vaccine Product Portfolio Table 140. CZ Veterinaria Recent Development Table 141. Colorado Serum Company Company Information Table 142. Colorado Serum Company Business Overview Table 143. Colorado Serum Company Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Colorado Serum Company Brucella Abortus Vaccine Product Portfolio Table 145. Colorado Serum Company Recent Development Table 146. CEVA Company Information Table 147. CEVA Business Overview Table 148. CEVA Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. CEVA Brucella Abortus Vaccine Product Portfolio Table 150. CEVA Recent Development Table 151. Centro Diagnostico Veterinario Company Information Table 152. Centro Diagnostico Veterinario Business Overview Table 153. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Portfolio Table 155. Centro Diagnostico Veterinario Recent Development Table 156. CAVAC Company Information Table 157. CAVAC Business Overview Table 158. CAVAC Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. CAVAC Brucella Abortus Vaccine Product Portfolio Table 160. CAVAC Recent Development Table 161. Biovet Company Information Table 162. Biovet Business Overview Table 163. Biovet Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 164. Biovet Brucella Abortus Vaccine Product Portfolio Table 165. Biovet Recent Development Table 166. Biogenesis Bago Company Information Table 167. Biogenesis Bago Business Overview Table 168. Biogenesis Bago Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 169. Biogenesis Bago Brucella Abortus Vaccine Product Portfolio Table 170. Biogenesis Bago Recent Development Table 171. North America Brucella Abortus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 172. North America Brucella Abortus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 173. North America Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 174. North America Brucella Abortus Vaccine Sales by Type (2027-2032) & (k units) Table 175. North America Brucella Abortus Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 176. North America Brucella Abortus Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 177. North America Brucella Abortus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 178. North America Brucella Abortus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 179. North America Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 180. North America Brucella Abortus Vaccine Sales by Application (2027-2032) & (k units) Table 181. North America Brucella Abortus Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 182. North America Brucella Abortus Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 183. North America Brucella Abortus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. North America Brucella Abortus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. North America Brucella Abortus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. North America Brucella Abortus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 187. North America Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 188. North America Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 189. North America Brucella Abortus Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 190. North America Brucella Abortus Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 191. United States Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 192. Canada Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 193. Mexico Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 194. Europe Brucella Abortus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 195. Europe Brucella Abortus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 196. Europe Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 197. Europe Brucella Abortus Vaccine Sales by Type (2027-2032) & (k units) Table 198. Europe Brucella Abortus Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 199. Europe Brucella Abortus Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 200. Europe Brucella Abortus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 201. Europe Brucella Abortus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 202. Europe Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 203. Europe Brucella Abortus Vaccine Sales by Application (2027-2032) & (k units) Table 204. Europe Brucella Abortus Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 205. Europe Brucella Abortus Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 206. Europe Brucella Abortus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. Europe Brucella Abortus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. Europe Brucella Abortus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. Europe Brucella Abortus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 210. Europe Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 211. Europe Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 212. Europe Brucella Abortus Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 213. Europe Brucella Abortus Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 214. Germany Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 215. France Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 216. U.K. Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Italy Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Russia Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 219. Spain Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Netherlands Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Switzerland Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Sweden Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 223. Poland Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 224. China Brucella Abortus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 225. China Brucella Abortus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 226. China Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 227. China Brucella Abortus Vaccine Sales by Type (2027-2032) & (k units) Table 228. China Brucella Abortus Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 229. China Brucella Abortus Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 230. China Brucella Abortus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 231. China Brucella Abortus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 232. China Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 233. China Brucella Abortus Vaccine Sales by Application (2027-2032) & (k units) Table 234. China Brucella Abortus Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 235. China Brucella Abortus Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 236. Asia Brucella Abortus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 237. Asia Brucella Abortus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 238. Asia Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 239. Asia Brucella Abortus Vaccine Sales by Type (2027-2032) & (k units) Table 240. Asia Brucella Abortus Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 241. Asia Brucella Abortus Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 242. Asia Brucella Abortus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 243. Asia Brucella Abortus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 244. Asia Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 245. Asia Brucella Abortus Vaccine Sales by Application (2027-2032) & (k units) Table 246. Asia Brucella Abortus Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 247. Asia Brucella Abortus Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 248. Asia Brucella Abortus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 249. Asia Brucella Abortus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 250. Asia Brucella Abortus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 251. Asia Brucella Abortus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 252. Asia Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 253. Asia Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 254. Asia Brucella Abortus Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 255. Asia Brucella Abortus Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 256. Japan Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 257. South Korea Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 258. India Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 259. Australia Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 260. Taiwan Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 261. Southeast Asia Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 262. SAMEA Brucella Abortus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 263. SAMEA Brucella Abortus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 264. SAMEA Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 265. SAMEA Brucella Abortus Vaccine Sales by Type (2027-2032) & (k units) Table 266. SAMEA Brucella Abortus Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 267. SAMEA Brucella Abortus Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 268. SAMEA Brucella Abortus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 269. SAMEA Brucella Abortus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 270. SAMEA Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 271. SAMEA Brucella Abortus Vaccine Sales by Application (2027-2032) & (k units) Table 272. SAMEA Brucella Abortus Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 273. SAMEA Brucella Abortus Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 274. SAMEA Brucella Abortus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 275. SAMEA Brucella Abortus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 276. SAMEA Brucella Abortus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 277. SAMEA Brucella Abortus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 278. SAMEA Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 279. SAMEA Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 280. SAMEA Brucella Abortus Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 281. SAMEA Brucella Abortus Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 282. Brazil Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 283. Argentina Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 284. Chile Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 285. Colombia Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 286. Peru Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 287. Saudi Arabia Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 288. Israel Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 289. UAE Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 290. Turkey Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 291. Iran Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 292. Egypt Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Table 293. Key Raw Materials Table 294. Raw Materials Key Suppliers Table 295. Brucella Abortus Vaccine Distributors List Table 296. Brucella Abortus Vaccine Customers List Table 297. Research Programs/Design for This Report Table 298. Authors List of This Report Table 299. Secondary Sources Table 300. Primary Sources List of Figures Figure 1. Brucella Abortus Vaccine Image Figure 2. Global Brucella Abortus Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brucella Abortus Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Vector Vaccines Image Figure 5. Subunit Vaccines Image Figure 6. DNA Vaccines Image Figure 7. B. Abortus Recombinant Mutants Image Figure 8. Others Image Figure 9. Global Brucella Abortus Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Brucella Abortus Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 11. Pigs Image Figure 12. Sheep Image Figure 13. Cattles Image Figure 14. Others Image Figure 15. Global Brucella Abortus Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Figure 17. Global Brucella Abortus Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Brucella Abortus Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Brucella Abortus Vaccine Revenue Market Share by Region (2021-2032) Figure 20. Global Brucella Abortus Vaccine Sales (2021-2032) & (k units) Figure 21. Global Brucella Abortus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global Brucella Abortus Vaccine Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Brucella Abortus Vaccine Sales YoY (2021-2032) & (k units) Figure 24. Europe Brucella Abortus Vaccine Sales YoY (2021-2032) & (k units) Figure 25. China Brucella Abortus Vaccine Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) Brucella Abortus Vaccine Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa Brucella Abortus Vaccine Sales YoY (2021-2032) & (k units) Figure 28. Global Brucella Abortus Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Brucella Abortus Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Brucella Abortus Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Brucella Abortus Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Brucella Abortus Vaccine Revenue Market Share by Type (2021-2032) Figure 34. Global Brucella Abortus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global Brucella Abortus Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Brucella Abortus Vaccine Sales Market Share by Type (2021-2032) Figure 37. Global Brucella Abortus Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Brucella Abortus Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Brucella Abortus Vaccine Revenue Market Share by Application (2021-2032) Figure 40. Global Brucella Abortus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global Brucella Abortus Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Brucella Abortus Vaccine Sales Market Share by Application (2021-2032) Figure 43. North America Brucella Abortus Vaccine Revenue Share by Type (2021-2032) Figure 44. North America Brucella Abortus Vaccine Sales Share by Type (2021-2032) Figure 45. North America Brucella Abortus Vaccine Revenue Share by Application (2021-2032) Figure 46. North America Brucella Abortus Vaccine Sales Share by Application (2021-2032) Figure 47. North America Brucella Abortus Vaccine Revenue Share by Country (2021-2032) Figure 48. North America Brucella Abortus Vaccine Sales Share by Country (2021-2032) Figure 49. Europe Brucella Abortus Vaccine Revenue Share by Type (2021-2032) Figure 50. Europe Brucella Abortus Vaccine Sales Share by Type (2021-2032) Figure 51. Europe Brucella Abortus Vaccine Revenue Share by Application (2021-2032) Figure 52. Europe Brucella Abortus Vaccine Sales Share by Application (2021-2032) Figure 53. Europe Brucella Abortus Vaccine Revenue Share by Country (2021-2032) Figure 54. Europe Brucella Abortus Vaccine Sales Share by Country (2021-2032) Figure 55. China Brucella Abortus Vaccine Revenue Share by Type (2021-2032) Figure 56. China Brucella Abortus Vaccine Sales Share by Type (2021-2032) Figure 57. China Brucella Abortus Vaccine Revenue Share by Application (2021-2032) Figure 58. China Brucella Abortus Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Brucella Abortus Vaccine Revenue Share by Type (2021-2032) Figure 60. Asia Brucella Abortus Vaccine Sales Share by Type (2021-2032) Figure 61. Asia Brucella Abortus Vaccine Revenue Share by Application (2021-2032) Figure 62. Asia Brucella Abortus Vaccine Sales Share by Application (2021-2032) Figure 63. Asia Brucella Abortus Vaccine Revenue Share by Country (2021-2032) Figure 64. Asia Brucella Abortus Vaccine Sales Share by Country (2021-2032) Figure 65. SAMEA Brucella Abortus Vaccine Revenue Share by Type (2021-2032) Figure 66. SAMEA Brucella Abortus Vaccine Sales Share by Type (2021-2032) Figure 67. SAMEA Brucella Abortus Vaccine Revenue Share by Application (2021-2032) Figure 68. SAMEA Brucella Abortus Vaccine Sales Share by Application (2021-2032) Figure 69. SAMEA Brucella Abortus Vaccine Revenue Share by Country (2021-2032) Figure 70. SAMEA Brucella Abortus Vaccine Sales Share by Country (2021-2032) Figure 71. Brucella Abortus Vaccine Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Brucella Abortus Vaccine Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Vector Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • B. Abortus Recombinant Mutants
  • Others
Applications
  • Pigs
  • Sheep
  • Cattles
  • Others
Companies covered
  • Zoetis
  • Qilu Animal Health
  • Merck Animal Health
  • Vetal
  • VECOL
  • Tecnovax
  • SYVA Laboratorios
  • Onderstepoort Biological Products
  • Merial
  • JOVAC
  • Instituto Rosenbusch
  • Institute of Animal Health and Veterinary Biologicals
  • Indian Immunologicals
  • Hester Biosciences
  • Dollvet
  • CZ Veterinaria
  • Colorado Serum Company
  • CEVA
  • Centro Diagnostico Veterinario
  • CAVAC
  • Biovet
  • Biogenesis Bago

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Brucella Abortus Vaccine Market by Type
  3. 1.2.1 Global Brucella Abortus Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Vector Vaccines
  5. 1.2.3 Subunit Vaccines
  6. 1.2.4 DNA Vaccines
  7. 1.2.5 B. Abortus Recombinant Mutants
  8. 1.2.6 Others
  9. 1.3 Brucella Abortus Vaccine Market by Application
  10. 1.3.1 Global Brucella Abortus Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Pigs
  12. 1.3.3 Sheep
  13. 1.3.4 Cattles
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Brucella Abortus Vaccine Market Dynamics
  1. 2.1 Brucella Abortus Vaccine Industry Trends
  2. 2.2 Brucella Abortus Vaccine Industry Drivers
  3. 2.3 Brucella Abortus Vaccine Industry Opportunities and Challenges
  4. 2.4 Brucella Abortus Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Brucella Abortus Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Brucella Abortus Vaccine Revenue by Region
  3. 3.2.1 Global Brucella Abortus Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Brucella Abortus Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Brucella Abortus Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Brucella Abortus Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Brucella Abortus Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Brucella Abortus Vaccine Sales by Region
  9. 3.4.1 Global Brucella Abortus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Brucella Abortus Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Brucella Abortus Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Brucella Abortus Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Brucella Abortus Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Brucella Abortus Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Brucella Abortus Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Brucella Abortus Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Brucella Abortus Vaccine Sales by Manufacturers
  6. 4.2.1 Global Brucella Abortus Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Brucella Abortus Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Brucella Abortus Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Brucella Abortus Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Brucella Abortus Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Brucella Abortus Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Brucella Abortus Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Brucella Abortus Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Brucella Abortus Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Brucella Abortus Vaccine Tier 1, Tier 2, and Tier 3
5 Brucella Abortus Vaccine Market by Type
  1. 5.1 Global Brucella Abortus Vaccine Revenue by Type
  2. 5.1.1 Global Brucella Abortus Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Brucella Abortus Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Brucella Abortus Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Brucella Abortus Vaccine Sales by Type
  6. 5.2.1 Global Brucella Abortus Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Brucella Abortus Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Brucella Abortus Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Brucella Abortus Vaccine Price by Type
6 Brucella Abortus Vaccine Market by Application
  1. 6.1 Global Brucella Abortus Vaccine Revenue by Application
  2. 6.1.1 Global Brucella Abortus Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Brucella Abortus Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Brucella Abortus Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Brucella Abortus Vaccine Sales by Application
  6. 6.2.1 Global Brucella Abortus Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Brucella Abortus Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Brucella Abortus Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Brucella Abortus Vaccine Price by Application
7 Company Profiles
  1. 7.1 Zoetis
  2. 7.1.1 Zoetis Company Information
  3. 7.1.2 Zoetis Business Overview
  4. 7.1.3 Zoetis Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Brucella Abortus Vaccine Product Portfolio
  6. 7.1.5 Zoetis Recent Developments
  7. 7.2 Qilu Animal Health
  8. 7.2.1 Qilu Animal Health Company Information
  9. 7.2.2 Qilu Animal Health Business Overview
  10. 7.2.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Qilu Animal Health Brucella Abortus Vaccine Product Portfolio
  12. 7.2.5 Qilu Animal Health Recent Developments
  13. 7.3 Merck Animal Health
  14. 7.3.1 Merck Animal Health Company Information
  15. 7.3.2 Merck Animal Health Business Overview
  16. 7.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Animal Health Brucella Abortus Vaccine Product Portfolio
  18. 7.3.5 Merck Animal Health Recent Developments
  19. 7.4 Vetal
  20. 7.4.1 Vetal Company Information
  21. 7.4.2 Vetal Business Overview
  22. 7.4.3 Vetal Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Vetal Brucella Abortus Vaccine Product Portfolio
  24. 7.4.5 Vetal Recent Developments
  25. 7.5 VECOL
  26. 7.5.1 VECOL Company Information
  27. 7.5.2 VECOL Business Overview
  28. 7.5.3 VECOL Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 VECOL Brucella Abortus Vaccine Product Portfolio
  30. 7.5.5 VECOL Recent Developments
  31. 7.6 Tecnovax
  32. 7.6.1 Tecnovax Company Information
  33. 7.6.2 Tecnovax Business Overview
  34. 7.6.3 Tecnovax Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Tecnovax Brucella Abortus Vaccine Product Portfolio
  36. 7.6.5 Tecnovax Recent Developments
  37. 7.7 SYVA Laboratorios
  38. 7.7.1 SYVA Laboratorios Company Information
  39. 7.7.2 SYVA Laboratorios Business Overview
  40. 7.7.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 SYVA Laboratorios Brucella Abortus Vaccine Product Portfolio
  42. 7.7.5 SYVA Laboratorios Recent Developments
  43. 7.8 Onderstepoort Biological Products
  44. 7.8.1 Onderstepoort Biological Products Company Information
  45. 7.8.2 Onderstepoort Biological Products Business Overview
  46. 7.8.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Onderstepoort Biological Products Brucella Abortus Vaccine Product Portfolio
  48. 7.8.5 Onderstepoort Biological Products Recent Developments
  49. 7.9 Merial
  50. 7.9.1 Merial Company Information
  51. 7.9.2 Merial Business Overview
  52. 7.9.3 Merial Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Merial Brucella Abortus Vaccine Product Portfolio
  54. 7.9.5 Merial Recent Developments
  55. 7.10 JOVAC
  56. 7.10.1 JOVAC Company Information
  57. 7.10.2 JOVAC Business Overview
  58. 7.10.3 JOVAC Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 JOVAC Brucella Abortus Vaccine Product Portfolio
  60. 7.10.5 JOVAC Recent Developments
  61. 7.11 Instituto Rosenbusch
  62. 7.11.1 Instituto Rosenbusch Company Information
  63. 7.11.2 Instituto Rosenbusch Business Overview
  64. 7.11.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Instituto Rosenbusch Brucella Abortus Vaccine Product Portfolio
  66. 7.11.5 Instituto Rosenbusch Recent Developments
  67. 7.12 Institute of Animal Health and Veterinary Biologicals
  68. 7.12.1 Institute of Animal Health and Veterinary Biologicals Company Information
  69. 7.12.2 Institute of Animal Health and Veterinary Biologicals Business Overview
  70. 7.12.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Portfolio
  72. 7.12.5 Institute of Animal Health and Veterinary Biologicals Recent Developments
  73. 7.13 Indian Immunologicals
  74. 7.13.1 Indian Immunologicals Company Information
  75. 7.13.2 Indian Immunologicals Business Overview
  76. 7.13.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Indian Immunologicals Brucella Abortus Vaccine Product Portfolio
  78. 7.13.5 Indian Immunologicals Recent Developments
  79. 7.14 Hester Biosciences
  80. 7.14.1 Hester Biosciences Company Information
  81. 7.14.2 Hester Biosciences Business Overview
  82. 7.14.3 Hester Biosciences Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Hester Biosciences Brucella Abortus Vaccine Product Portfolio
  84. 7.14.5 Hester Biosciences Recent Developments
  85. 7.15 Dollvet
  86. 7.15.1 Dollvet Company Information
  87. 7.15.2 Dollvet Business Overview
  88. 7.15.3 Dollvet Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Dollvet Brucella Abortus Vaccine Product Portfolio
  90. 7.15.5 Dollvet Recent Developments
  91. 7.16 CZ Veterinaria
  92. 7.16.1 CZ Veterinaria Company Information
  93. 7.16.2 CZ Veterinaria Business Overview
  94. 7.16.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 CZ Veterinaria Brucella Abortus Vaccine Product Portfolio
  96. 7.16.5 CZ Veterinaria Recent Developments
  97. 7.17 Colorado Serum Company
  98. 7.17.1 Colorado Serum Company Company Information
  99. 7.17.2 Colorado Serum Company Business Overview
  100. 7.17.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Colorado Serum Company Brucella Abortus Vaccine Product Portfolio
  102. 7.17.5 Colorado Serum Company Recent Developments
  103. 7.18 CEVA
  104. 7.18.1 CEVA Company Information
  105. 7.18.2 CEVA Business Overview
  106. 7.18.3 CEVA Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 CEVA Brucella Abortus Vaccine Product Portfolio
  108. 7.18.5 CEVA Recent Developments
  109. 7.19 Centro Diagnostico Veterinario
  110. 7.19.1 Centro Diagnostico Veterinario Company Information
  111. 7.19.2 Centro Diagnostico Veterinario Business Overview
  112. 7.19.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Portfolio
  114. 7.19.5 Centro Diagnostico Veterinario Recent Developments
  115. 7.20 CAVAC
  116. 7.20.1 CAVAC Company Information
  117. 7.20.2 CAVAC Business Overview
  118. 7.20.3 CAVAC Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 CAVAC Brucella Abortus Vaccine Product Portfolio
  120. 7.20.5 CAVAC Recent Developments
  121. 7.21 Biovet
  122. 7.21.1 Biovet Company Information
  123. 7.21.2 Biovet Business Overview
  124. 7.21.3 Biovet Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Biovet Brucella Abortus Vaccine Product Portfolio
  126. 7.21.5 Biovet Recent Developments
  127. 7.22 Biogenesis Bago
  128. 7.22.1 Biogenesis Bago Company Information
  129. 7.22.2 Biogenesis Bago Business Overview
  130. 7.22.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Biogenesis Bago Brucella Abortus Vaccine Product Portfolio
  132. 7.22.5 Biogenesis Bago Recent Developments
8 North America
  1. 8.1 North America Brucella Abortus Vaccine Market Size by Type
  2. 8.1.1 North America Brucella Abortus Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Brucella Abortus Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Brucella Abortus Vaccine Price by Type (2021-2032)
  5. 8.2 North America Brucella Abortus Vaccine Market Size by Application
  6. 8.2.1 North America Brucella Abortus Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Brucella Abortus Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Brucella Abortus Vaccine Price by Application (2021-2032)
  9. 8.3 North America Brucella Abortus Vaccine Market Size by Country
  10. 8.3.1 North America Brucella Abortus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Brucella Abortus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Brucella Abortus Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Brucella Abortus Vaccine Market Size by Type
  2. 9.1.1 Europe Brucella Abortus Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Brucella Abortus Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Brucella Abortus Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Brucella Abortus Vaccine Market Size by Application
  6. 9.2.1 Europe Brucella Abortus Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Brucella Abortus Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Brucella Abortus Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Brucella Abortus Vaccine Market Size by Country
  10. 9.3.1 Europe Brucella Abortus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Brucella Abortus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Brucella Abortus Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Brucella Abortus Vaccine Market Size by Type
  2. 10.1.1 China Brucella Abortus Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Brucella Abortus Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Brucella Abortus Vaccine Price by Type (2021-2032)
  5. 10.2 China Brucella Abortus Vaccine Market Size by Application
  6. 10.2.1 China Brucella Abortus Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Brucella Abortus Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Brucella Abortus Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Brucella Abortus Vaccine Market Size by Type
  2. 11.1.1 Asia Brucella Abortus Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Brucella Abortus Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Brucella Abortus Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Brucella Abortus Vaccine Market Size by Application
  6. 11.2.1 Asia Brucella Abortus Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Brucella Abortus Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Brucella Abortus Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Brucella Abortus Vaccine Market Size by Country
  10. 11.3.1 Asia Brucella Abortus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Brucella Abortus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Brucella Abortus Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Brucella Abortus Vaccine Market Size by Type
  2. 12.1.1 SAMEA Brucella Abortus Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Brucella Abortus Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Brucella Abortus Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Brucella Abortus Vaccine Market Size by Application
  6. 12.2.1 SAMEA Brucella Abortus Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Brucella Abortus Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Brucella Abortus Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Brucella Abortus Vaccine Market Size by Country
  10. 12.3.1 SAMEA Brucella Abortus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Brucella Abortus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Brucella Abortus Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Brucella Abortus Vaccine Value Chain Analysis
  2. 13.1.1 Brucella Abortus Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Brucella Abortus Vaccine Production Mode & Process
  6. 13.2 Brucella Abortus Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Brucella Abortus Vaccine Distributors
  9. 13.2.3 Brucella Abortus Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst